We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.3B
AUM Growth
-$3.3B
(-7.6%)
Cap. Flow
-$1.89B
Cap. Flow
% of AUM
-4.68%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
1,160
New
85
Increased
251
Reduced
431
Closed
113
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVLR
Avalara, Inc.
AVLR
|
+$150M |
| 2 |
EOG Resources
EOG
|
+$128M |
| 3 |
TJX Companies
TJX
|
+$122M |
| 4 |
RTX Corp
RTX
|
+$107M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$365M |
| 2 |
Burlington
BURL
|
+$216M |
| 3 |
Textron
TXT
|
+$190M |
| 4 |
Dollar Tree
DLTR
|
+$126M |
| 5 |
ExxonMobil
XOM
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.31% |
| 2 | Healthcare | 17.41% |
| 3 | Financials | 15.7% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Intuit
INTU
$87.1B
| $111M | 0.28% |
287,400
-7,100
| -2% | -$3.07M |
|
77
Elevance Health
ELV
$83B
| $111M | 0.28% |
244,493
-6,600
| -3% | -$3.16M |
|
78
McDonald's
MCD
$191B
| $110M | 0.27% |
476,902
-155,250
| -25% | -$39.7M |
|
79
Emerson Electric
EMR
$86.7B
| $109M | 0.27% |
1,492,596
+773,360
| +108% | +$64.2M |
|
80
Chubb
CB
$134B
| $108M | 0.27% |
595,483
+189,200
| +47% | +$35.9M |
|
81
Morgan Stanley
MS
$332B
| $107M | 0.26% |
1,349,334
-38,100
| -3% | -$3.21M |
|
82
S&P Global
SPGI
$123B
| $106M | 0.26% |
347,120
-129,400
| -27% | -$46.3M |
|
83
T-Mobile US
TMUS
$190B
| $106M | 0.26% |
788,234
-65,400
| -8% | -$9.18M |
|
84
Goldman Sachs
GS
$303B
| $106M | 0.26% |
360,209
-61,900
| -15% | -$20.1M |
|
|
ERF
85
DELISTED
Enerplus Corporation
ERF
| $104M | 0.26% |
7,320,964
-516,798
| -7% | -$7.25M |
|
86
Ovintiv
OVV
$17.1B
| $103M | 0.26% |
2,239,949
+190,000
| +9% | +$9.08M |
|
87
Advanced Micro Devices
AMD
$846B
| $102M | 0.25% |
1,609,694
-78,000
| -5% | -$6.64M |
|
88
Lockheed Martin
LMT
$135B
| $102M | 0.25% |
263,068
+15,870
| +6% | +$6.63M |
|
89
Netflix
NFLX
$306B
| $101M | 0.25% |
4,310,330
-67,000
| -2% | -$1.49M |
|
90
PayPal
PYPL
$50.1B
| $101M | 0.25% |
1,178,375
-27,700
| -2% | -$2.46M |
|
91
KeyCorp
KEY
$24.5B
| $101M | 0.25% |
6,300,169
+1,829,000
| +41% | +$32.7M |
|
92
Prologis
PLD
$135B
| $99.6M | 0.25% |
980,629
+216,720
| +28% | +$26.9M |
|
|
CINC
93
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $99.4M | 0.25% |
3,029,427
+763,966
| +34% | +$21.6M |
|
|
MRTX
94
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $99.1M | 0.25% |
+1,418,747
| New | +$105M |
|
95
Intel
INTC
$509B
| $98.8M | 0.25% |
3,833,285
-175,200
| -4% | -$5.97M |
|
96
Corebridge Financial
CRBG
$14.1B
| $98.3M | 0.24% |
+4,994,123
| New | +$103M |
|
97
Sarepta Therapeutics
SRPT
$1.68B
| $97.8M | 0.24% |
885,000
-380,000
| -30% | -$38.3M |
|
98
Vertex Pharmaceuticals
VRTX
$119B
| $97.6M | 0.24% |
337,163
-234,867
| -41% | -$67.6M |
|
99
Deere & Co
DE
$163B
| $97.5M | 0.24% |
292,094
+1,385
| +0.5% | +$474K |
|
100
Alnylam Pharmaceuticals
ALNY
$29.5B
| $97.1M | 0.24% |
485,000
+315,000
| +185% | +$60.1M |
|
Similar funds
Adage Capital Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Adage Capital Partners held 1,160 positions worth $40.3B, down 7.6% from $43.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.89B in Q3 2022, closing 113 positions and reducing 431 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $101M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Avalara, Inc. worth $153M.
- Adage Capital Partners's largest Q3 2022 buy was Avalara, Inc.: 1,670,000 shares worth $153M.
- Adage Capital Partners added most to EOG Resources in Q3 2022, an estimated $128M increase.
- Adage Capital Partners's biggest Q3 2022 reduction was Royalty Pharma, cutting an estimated $365M.
- Adage Capital Partners fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $101M.
- Adage Capital Partners's ten largest holdings make up 21% of its $40.3B portfolio in Q3 2022.
- Adage Capital Partners opened 85 new positions and closed 113 in Q3 2022.
- Adage Capital Partners's portfolio value fell 7.6% quarter-over-quarter to $40.3B.
Based on Adage Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.